More Ionis Pharmaceuticals, Inc. news Ionis Pharmaceuticals, Inc.NASDAQ: IONS Olezarsen significantly reduces triglycerides and acute pancreatitis events in landmark pivotal studies for people with severe hypertriglyceridemia (sHTG) Sep 2, 2025 · Issued by Ionis Pharmaceuticals, Inc. As issuedPlain English Watch Ionis Pharmaceuticals explain it↗Ionis Pharmaceuticals, Inc. (IONS) Q2 2026 Earnings Call · Replay · Jul 29 – Up to 72% (p
